Anders Olsson

Anders Olsson is a Safety Manager and Deputy QPPV at Camurus, where they focus on pharmacovigilance and regulatory affairs. They previously held the position of Pharmacovigilance Manager at Hansa Biopharma and served as a Safety Surveillance Adviser at Novo Nordisk. Anders earned a Ph.D. in Experimental Endocrinology and Genetics and worked as a Research Associate at Lund University, investigating the genetic and epigenetic mechanisms behind type 2 diabetes. Additionally, they completed a postdoctoral fellowship at Rigshospitalet, focusing on metabolic disease.